● Designing 50+ Sessions of Scientific Forums, Symposia, Roundtables, Dialogs, Workshops and Training
Courses
● Inviting Worldwide Distinguished Experts, Investors, and Decision Makers in the areas of Drug Discovery for
the Grand Thought Collision from 30+ Countries
● Shooting for 200+ Oral Presentations and Hot Paper Briefing in whole Spectrum of Drug Discovery Fields
● Gathering 50+ Exhibitors in Cutting-edge Technologies and Novel Bioproducts
● Bringing in 20+ Professional Media Supporters
● Scheduling 5+ Sessions of Business & Career Development, and Talent Search
● Multi-Zones of Poster Show and Exhibitions of New Finding, New IP, New Tech and New Products
 |
Dr. Ada E. Yonath |
 |
Dr. Maode Lai |
 |
Dr. David Horne |
 |
Dr. Yoshinori Ikeura |
 |
Dr. Henrietta Ukwu |
 |
Dr. Pavel Hobza |
 |
Dr. Richard Soll Senior Vice President and Head of International Discovery Service Unit,WuXi AppTec, USA |
 |
Dr. Sudhakar Garad Global Head, Chemical and Pharmaceutical Profiling, Novartis, USA |
 |
Dr. Stephan Zahn Director, Boehringer Ingelheim RCV GmbH & Co KG, Austria |
 |
Dr. Zhenhong Li Senior Director, REGENXBIO Inc., USA |
 |
Dr. Bruce A. Littlefield Distinguished Scientist and Head, Translational Medicine, Global Oncology, Eisai Inc., USA |
 |
Dr. David C. Bunton CEO, REPROCELL Europe Ltd., UK |
 |
Dr. Qidong You Professor and Dean of School of Pharmacy, China Pharmaceutical University, China |
 |
Dr. Luzheng Xue Professor, University of Oxford, UK |
 |
Dr. Bruce Given COO, Arrowhead Research Corporation, USA |
 |
Dr. Dieter Lubda Director, Merck KGaA, Germany |
 |
Dr. Qi Yin Clinical Sciences Therapeutic Area Head, Cardiovascular and Metabolic Diseases, Novartis Institutes for BioMedical Research, USA |
 |
Dr. Chilakamarri Rangacharyulu Professor, University of Saskatchewan, Canada |
 |
Dr. Steffen Denzinger Director Business Development Actives & Formulation, Process Solutions/Life Science, Merck, Germany |
 |
Dr. Tina Tao Head of APAC E2E Biodevelopment Center, Merck Group, China |
 |
Dr. Kiyoshi Nokihara CEO&CSO, HiPepLaboratories, Japan |
 |
Dr. Cheng Zhang Chief Scientific Officer, Gmax BioPharm, China |
 |
Dr. Hong Ling VP of Innovation, Head of Pipeline and Scientific Evaluation, Qilu Pharmaceuticals, China |
 |
Dr. Yan Wu Vice President, Head of Clinical Operation and Head of Immunology Development, Hutchison Medi Pharma, China |
 |
Dr. Emil Fu Senior VP, International Integration, Fountain Medical Development, China |
 |
Dr. Jaya Abraham President R&D, Koru Lifescience, Auckland |
 |
Dr.
Beat Flühmann Director, Vifor Pharma Ltd, Switzerland |
 |
Dr. Ghotas Evindar Chemistry Group Leader, GlaxoSmithKline, USA |
 |
Dr. John Lambert Corporate Vice President and Chief Medical Officer, PAREXEL International Shanghai, China |
 |
Dr. Gerald J. Yakatan Chairman & CEO, IriSys, LLC,.USA |
 |
Dr. Zaihui Zhang CSO and VP R&D, Signalchem Lifesciences Corp., Canada |
 |
Dr. Chris Triggle Professor, Weill Cornell Medicine, Qatar |
 |
Dr. Weiyi Zhang Director, External Innovation China Research Beyond Borders, Corporate Discovery Research, Boehringer-IngelheimPharma, China |
 |
Dr. Gert Fricker Director, Institute of Pharmacy and Molecular Biotechnology, Ruprecht-Karls University, Germany |
|
Dr. Ningsun Yang Distinguished Research Fellow and Chair Professor, Academia Sinica, Taiwan |
 |
Dr. Jing Li Senior Vice President, Biologics Discovery, Wuxi Biologics, China |
 |
Dr. Chris Vernall Business Development Director, Intertek Melbourn, UK |
 |
Dr. Robert Borris Vice-Dean, School of Pharmaceutical Science and Technology, Tianjin University, China |
 |
Dr. Yimin Chao Professor, University of East Anglia, UK |
 |
Dr. Amy Guan Vice President, HaiyanPharma of Yangtzi River Pharmaceutical Groups, China |
 |
Dr. Xingchun Gou Professor, Xi'an Medical University, China |
 |
Dr. Alan A.Chalmers Director, Pharma International, Switzerland |
 |
Dr. Rakesh Ranjan Executive Medical Director, Charak Clinical Research Center, USA |
 |
Dr. Chin-Tarng Lin Professor, National Taiwan University Hospital, Taiwan |
 |
Dr. Ole Winther Rasmussen Associate Professor, Medical Department, Kolding Hospital, Denmark |
 |
Dr. Guo-Ping Zhou Adjunct Professor, Harvard Medical School, USA |
 |
Dr. Wei Min Huang Associate Professor, School of Mechanical and Aerospace Engineering, Nanyang Technological University, Singapore |
 |
Dr. Shengjun Zhang Vice President and Chief Medical Officer, JOINN Laboratories, China |
 |
Dr. Iduna Jutta Fichtner COO, EPO-Experimental Pharmacology and Oncology GmbH, Germany |
 |
Dr. James (Jim) Radosevich Chief Scientific Officer, LabyRx Immunologic Therapeutics Limited, USA |
 |
Dr. Thomas Vorherr Director Peptide Discovery, Novartis Institutes for BioMedical Research, Switzerland |
 |
Dr. Le Sun President, AbMax Biotechnology Co., Ltd., China |
 |
Dr. Xiangdong Qu CEO, QureBio, China |
 |
Dr. George E. Anastassov Founder, AXIM Biotechnologies, Inc., USA |
 |
Dr. Sridhar Iyer Deputy Director& GlobalHead-Business Development, JRF Global, India |
 |
Dr. Abhay Deshpande Director, Global Innovation & Strategy, JRF Global, India |
 |
Dr. Sue Xue Ming Professor,Rutgers New Jersey Medical School, USA |
 |
Dr. Pavel Hobza Professor, Academy of Sciences of the Czech Republic, Czech Republic |
 |
Dr. Imre Molnar President, Molnar-Institute for applied chromatograph, Germany |
 |
Dr. Yinsheng Zhang Vice President of Pharmaceutical R&D Institute, Chia Tai Tianqing Pharmaceutical Group Co., Ltd, China |
 |
Dr. Guofeng You Distinguished Professor，Rutgers University, USA |
 |
Dr. Qiang Liu Director of Antibody Engineering, Twist Bioscience, USA |
 |
Dr. Yong Qian President, BioMedicure LLC., China |
Nanjing is the capital of Jiangsu Province in East China, running through the city are lower
reaches of the Yangtze River whose estuary is not far away. Nanjing enjoys a civilization of over 6000 years
and the city itself was founded 2500 years ago. Enclosed by mountains and rivers, and located in a strategic
place, it boasts picturesque scenery that blends natural landscape with towering modern buildings,
integrating traditional styles with modern civilization. Thus it was known as a unique historic and cultural
city to the world.
As one of the Four Ancient Capitals, Nanjing is a vital cradle of Chinese civilization and over a long
stretch of time, it has been the political and cultural pivot of South China, thus dubbed as the Capital of
Ten Ancient Dynasties, rich in both cultural heritage and historical relics. Among the landmarks of Nanjing
there are the City Wall, the Ming Xiaoling Mausoleum, Dr. Sun Yat-sen Mausoleum, Presidential Palace and
Confucius Temple.
Nanjing Municipal Investment Promotion Bureau
Nanjing Municipal Science and Technology Bureau
District People's Government of Jiangning Nanjing
China Biopharma Parks Cluster Alliance
Jiangsu Pharmaceutical Association
Nanjing Medical University
Nanjing University of Posts and Telecommunications
Administration Committee of Nanjing Jiangning Hi-Tech Development Zone
Information Research Center of International Talent, State Administration of Foreign Experts Affairs, China
Jiangsu Drug Research and Development Association
Editorial Board of Progress in Pharmaceutical Sciences
Journal of Pharmaceutical and Clinical Research
GenScript Biotechnology Co.,Ltd
BIT Congress Inc.
GenScript Biotechnology Co.,Ltd.
Molnar-Institute for applied chromatography
Chengdu Jian River Pharmaceuticals Co.,Ltd.
Anhui General Biosystems Co.,Ltd.
Molecular Devices, LLC.
Crown Bioscience Inc.
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2003-2019 BIT Group Global Ltd.